Maryland companies and private researchers are repairing spine damage, rebuilding torn cartilage and working on cures for autoimmune diseases such as Crohn?s disease and type 1 diabetes.
They are working largely on a patchwork of state, private and minimal federal funds. But with the suggestion of more funding coming from Congress, many feel their industry is about to open up.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.